InMode (INMD) Income from Continuing Operations (2018 - 2026)
InMode (INMD) posted quarterly Income from Continuing Operations of 11562000.0 for Q1 2026, down 36.48% year-on-year from 18201000.0 in Q1 2025, and down 67.49% on a QoQ basis from 35559000.0 in Q4 2025.
InMode (INMD) Income from Continuing Operations (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Income from Continuing Operations for 9 consecutive years, with 11562000.0 the latest figure, recorded in Q1 2026.
- Quarterly Income from Continuing Operations fell 36.48% year-over-year to 11562000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 95726000.0 (up 28.22% YoY) and the FY2025 annual result came in at 126829000.0, up 20.03% from the prior year.
- Income from Continuing Operations declined to 11562000.0 in Q1 2026 per INMD's latest filing, from 35559000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for INMD reached as high as 65163000.0 in Q4 2023 and fell as low as 18351000.0 in Q4 2024.
- A 5-year average of 33148058.82 and a median of 35559000.0 in 2025 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations sank 128.16% — and 2025, when it soared 293.77%.
- Year by year, Income from Continuing Operations stood at 37708000.0 in 2022, then jumped by 72.81% to 65163000.0 in 2023, then sank by 128.16% to 18351000.0 in 2024, then surged by 293.77% to 35559000.0 in 2025, then sank by 67.49% to 11562000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 11562000.0, 35559000.0, and 21863000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 11.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.56 Mn |
| Dec 31, 2025 | 35.56 Mn |
| Sep 30, 2025 | 21.86 Mn |
| Jun 30, 2025 | 26.74 Mn |
| Mar 31, 2025 | 18.20 Mn |
| Dec 31, 2024 | -18.35 Mn |
| Sep 30, 2024 | 50.99 Mn |
| Jun 30, 2024 | 23.82 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Dec 31, 2023 | 65.16 Mn |
| Sep 30, 2023 | 46.52 Mn |
| Jun 30, 2023 | 55.73 Mn |
| Mar 31, 2023 | 40.51 Mn |
| Dec 31, 2022 | 37.71 Mn |
| Sep 30, 2022 | 48.79 Mn |
| Jun 30, 2022 | 44.05 Mn |
| Mar 31, 2022 | 30.98 Mn |
| Dec 31, 2021 | 52.69 Mn |
| Sep 30, 2021 | 44.72 Mn |
| Jun 30, 2021 | 40.93 Mn |